September 20, 2017 2:24 AM ET

Biotechnology

Company Overview of ACADIA Pharmaceuticals Inc.

Executive Profile

Paul S. Anderson Ph.D.

Member of the Scientific and Clinical Advisory Board, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 organization across 14 different industries.

See Board Relationships
78--

Background

Dr. Paul S. Anderson, Ph.D., serves as Scientific Advisor at Centrose, LLC. Dr. Anderson has experience in the pharmaceutical industry spans nearly 40 years. Dr. Anderson served as a Vice President of Drug Discovery at Bristol-Myers Squibb Company from 2001 to 2002. He served as Senior Vice President of Chemical and Physical Sciences of the Dupont Pharmaceuticals from 1995 to 2001. He began his career at Merck Sharp and Dohme Research Laboratories where, in 1988, he ...

Corporate Headquarters

3611 Valley Centre Drive
San Diego, California 92130

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships

There is no Board Members Memberships data available.

Education

Honorary Doctorate
The University of Vermont
ScD 1998
The University of Vermont
BS 1959
The University of Vermont
PhD 1963
The University of New Hampshire, Durham

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
$772.5K
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer and President
Ionis Pharmaceuticals, Inc.
$2.0M
Arthur Joseph Higgins CEO, President & Director
Depomed, Inc.
--
Paul M. Bisaro President, CEO & Director
Impax Laboratories, Inc.
--
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ACADIA Pharmaceuticals Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.